Symptomatic improvement with gluten restriction in irritable bowel syndrome: a prospective, randomized, double blinded placebo controlled trial
| Autor: | Pravir A Gambhire, Qais Contractor, Pravin Rathi, Sunil V Pawar, Samit S Jain, Vinaya B Shah, Vinay Zanwar, Ravindra Surude |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2016 |
| Předmět: |
medicine.medical_specialty
Glutens Double blinded Non-celiac gluten sensitivity Placebo-controlled study lcsh:Medicine Gluten sensitivity Disease digestive system Gastroenterology 03 medical and health sciences 0302 clinical medicine Internal medicine Controlled clinical trial medicine lcsh:RC799-869 Irritable bowel syndrome chemistry.chemical_classification business.industry lcsh:R nutritional and metabolic diseases medicine.disease Gluten digestive system diseases chemistry Diet gluten-free 030220 oncology & carcinogenesis 030211 gastroenterology & hepatology Gluten free Original Article lcsh:Diseases of the digestive system. Gastroenterology business Wheat allergy |
| Zdroj: | Intestinal Research, Vol 14, Iss 4, Pp 343-350 (2016) Intestinal Research |
| ISSN: | 2288-1956 1598-9100 |
| Popis: | Background/Aims The existence of non-celiac gluten sensitivity has been debated. Indeed, the intestinal and extra-intestinal symptoms of many patients with irritable bowel syndrome (IBS) but without celiac disease or wheat allergy have been shown to improve on a gluten-free diet. Therefore, this study set out to evaluate the effects of gluten on IBS symptoms. Methods We performed a double-blind randomized placebo-controlled rechallenge trial in a tertiary care hospital with IBS patients who fulfilled the Rome III criteria. Patients with celiac disease and wheat allergy were appropriately excluded. The participants were administered a gluten-free diet for 4 weeks and were asked to complete a symptom-based questionnaire to assess their overall symptoms, abdominal pain, bloating, wind, and tiredness on the visual analog scale (0-100) at the baseline and every week thereafter. The participants who showed improvement were randomly assigned to one of two groups to receive either a placebo (gluten-free breads) or gluten (whole cereal breads) as a rechallenge for the next 4 weeks. Results In line with the protocol analysis, 60 patients completed the study. The overall symptom score on the visual analog scale was significantly different between the two groups (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|